Temperature Controlled Pharmaceutical Container Market Outlook for 2024 to 2034

The temperature controlled pharmaceutical containers market is set to enjoy a valuation of USD 4.8 billion in 2024, registering progression at a CAGR of 4.8% to reach USD 7.7 billion by 2034. Sales of such containers are anticipated to bolster with the top 3 countries estimated to hold around 35 to 40% of the market by the end of this forecast period.

Key Trends in the Temperature Controlled Pharmaceutical Container Market

  • The market holds around 13 to 15% of the temperature controlled pharma packaging solutions industry.
  • Regionally, North America and Europe, collectively, are projected to account for more than two-thirds of the market share during the initial period.
  • The flourishing growth of the life sciences sector can be tracked down to the new drug development activities influencing the current strategies of pharmaceutical companies.
  • Manufacturers in the global pharmaceutical industry are making use of the latest technologies to produce innovative medicines and drugs that require temperature modulation throughout the logistics chain.
Report Attribute Details
Temperature Controlled Pharmaceutical Container Market Size (2024) USD 4.8 billion
Market Anticipated Forecast Value (2034) USD 7.7 billion
Market Projected Growth Rate (2024 to 2034) 4.8% CAGR

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Demand Outlook of Temperature Controlled Pharmaceutical Container vs. Historical Consumption Trends

As per Future Market Insights (FMI), the temperature controlled pharmaceutical containers market witnessed a CAGR of 5.5% during the historic period with a market value of USD 4.6 billion in 2023, growing from USD 3.5 billion in 2019.

As many pharmacy companies started producing uncommon pharmaceuticals to combat the COVID-19 outbreak, the need for safe packaging surged during the years 2020 and 2021. Most of these medicines or drugs were sensitive to ambient temperature, resulting in cold chain logistics market trends hinging on temperature regulated pharmaceutical containers.

Attributes Details
Temperature Controlled Pharmaceutical Container Market Value (2019) USD 3.5 billion
Market Revenue (2023) USD 4.6 billion
Market Historical Growth Rate (CAGR 2019 to 2023) 5.5% CAGR

Prominent Factors Fueling the Temperature Controlled Pharmaceutical Container Market Growth

To ensure the safe delivery of critical products, service providers are now incorporating the latest technologies and launching innovative products. Further, as most temperature-sensitive medicines and vaccines are transported through airlines, vendors are entering into partnerships with leading airline and cargo companies.

The development of new drugs and therapies is expected to spur the industry growth factors for pharmaceutical containers. The market share of temperature controlled container brands meant for other commodities is also rising owing to the emergence of new pharmaceutical industries in developing economies.

Ismail Sutaria
Ismail Sutaria

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Country-wise Insights

Regional analysis of temperature controlled pharmaceutical container market figures out five countries with the most lucrative growth opportunities.

Regional Market Comparison CAGR (2024 to 2034)
United States 2.9%
Germany 2.5%
United Kingdom 2.7%
China 5.7%
India 6%

Technological Advancements are driving the United States Market

The United States temperature controlled pharmaceutical container market is witnessing growth trends that can exhibit a CAGR of 2.9% between 2024 and 2034. According to the International Federation of Pharmaceutical Manufacturers & Associations, the United States is currently the most developed pharmaceutical market across the globe.

The United States market is advancing fast due to higher investment in product design and the adoption of modern technologies to make it acceptable in other regions as well. The Pegasus ULD® from Sonoco ThermoSafe is the first passive bulk temperature-controlled ULD container for pharmaceutical use to receive FAA and EASA approval, allowing it to move quickly and cheaply through customs and handling procedures for international air freight.

Increased Commercial Efforts to Improve Logistics Sector in Germany

Demand for temperature controlled pharmaceutical containers in Germany is poised to increase at a rate of 2.5% per year through the projected time period. Germany being the leading manufacturer of industrial equipment in Europe is now emphasizing more on logistics equipment for a quick return.

Technological advancements are enabling the regional players to meet the increasing consumer demand for new and more effective medicines and pharmaceutical products. Also, recent developments in HVAC technology are expected to prove helpful to German manufacturers to produce more efficient temperature-sensitive containers industry in the region.

The United Kingdom Market to Benefit from Rising Production of Life-saving Drugs

The sales of temperature controlled pharmaceutical containers in the United Kingdom are poised to increase at 2.7% CAGR through 2034.

Using cloud technologies to gather, analyze, and visualize temperature data throughout transportation has boosted market perception and reliability of temperature controlled containers in the United Kingdom. Further, rising production and supply of life-saving drugs and vaccines across the country are expected to create lucrative prospects for the temperature controlled pharmaceutical container market.

Exports of Pharmaceuticals Require Temperature Controlled Containers More in China

The temperature controlled pharmaceutical container industry of China is on the path to achieve a CAGR of 5.7% over the forecast years. A sizable domestic market and export of pharmaceuticals have augmented the market forecast for the pharmaceutical container industry of the country.

Market forecasts for pharmaceutical container industries indicate a prolific rise in the regional market in China. In addition to that, with the presence of some leading pharmacy companies, market penetration strategies for temperature controlled containers are evolving fast in the country.

Surplus Pharmaceutical Manufacturing to Fuel Market Innovation in India

India has the 3rd largest pharmaceutical industry in terms of volume in comparison with all other countries across the globe. Hence, to keep the drugs safe from harsh temperatures and atmosphere, end users are increasing the adoption of temperature-controlled pharmaceutical containers.

With growing development in pharmaceutical manufacturing and supplying generic formulations across the globe, market trends driving innovation in pharmaceutical container solutions are expected to improve over the forecast period. So, sales of temperature controlled pharmaceutical containers in India are expected to develop at a 6% CAGR between 2024 and 2034.

Category-wise Insights

Over three-fourth of the Market Sales to be contributed by Chest Style

Based on product type, the chest style segment accounts for more than 75.5% of the market value share in 2024.

Attributes Details
Top Product Type Segment Chest Style
Total Market Share in 2024 to 2034 75.5%

Due to the higher thermal stability and operational qualification of chest-style containers, the product is gaining popularity. These systems are secure and allow users to quickly load and unload. Moreover, chest-style containers with active systems are temperature-controlled containers with monitoring systems that function with the help of electricity.

Chilled Containers are Preferred More by Pharmaceutical Distributors

Based on application chilled containers segment is figured to contribute to 42.9% of the total market sales in 2024.

Attributes Details
Top Application Type Segment Chilled
Total Market Share in 2024 42.9%

Temperature-controlled containers are designed to maintain temperature surroundings during the transportation of medical and drug supplies across the globe. Market research on temperature control technologies in containers also suggests chilled containers are more economical than other temperature containers. Hence, chilled containers are adopted more by pharmaceutical manufacturers to cater to the growing demand among patients and the rise of routine diseases.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Competitive Landscape for Temperature Controlled Pharmaceutical Container Market

Key players operating in the temperature-controlled pharmaceutical containers market are aiming to expand their production capabilities to meet the growing demand. They are also forming alliances and eyeing acquisition strategies to expand their resources. Meanwhile, some emerging players are developing new products to meet customer needs and gain a competitive edge. Also, these companies are focusing on upgrading their facilities to cater to the demand.

Recent Developments

  • Sonoco ThermoSafe, a division of Sonoco Incorporate based in the United States, joined hands with Singapore Airlines in 2021. This alliance will enable the leasing of the new Pegasus ULD® temperature-controlled bulk shipping container of Singapore Airlines. Also, as part of this partnership, Singapore Airlines and Sonoco's clients will also have access to more Sonoco ThermoSafe containers.
  • In addition to partnering with airliners and cargo companies, vendors are also concentrating on launching cutting-edge containers. For instance, Envirotainer introduced a cutting-edge new shipping container in May 2021 as COVID-19 vaccination exports that had just been authorized were increasing. The Releye® RLP container, the newest model in a well-established family of temperature-controlled air cargo containers and the first of its kind, is now redefining how medications and vaccinations are delivered.
  • Envirotainer also announced the debut of four models that reflect the CryoSure® platform, its newest shipping option for pharmaceuticals (X1, X2, X5, and X11). The performance at -70oC is one of many competitive features and capabilities offered by this platform. The CryoSure® technology is especially helpful for longer shipments and eliminates risks brought on by delays and human error, resulting in safer, more sustainable, and more dependable pharmaceutical delivery for the benefit of patients.

Key Players Profiled in the Temperature Controlled Pharmaceutical Container Market Report

  • Pelican Biothermal
  • Sonoco Product Company
  • Cryopak
  • Cold Chain Technologies
  • Envirotainer Ltd
  • Sofigram SA Ltd
  • Va Q Tec AG
  • Inmark Packaging
  • Softbox Systems
  • Sealed Air Corporation
  • Tempack
  • Intelsius
  • Saeplast Americas Inc.
  • Euroengel Srl
  • Klinge Corporation

Key Coverage in the Temperature Controlled Pharmaceutical Container Market Report

  1. Adjacent study on temperature-controlled pharmaceutical packaging market.
  • Market segmentation of temperature controlled containers and equipment.
  • Market analysis of pharmaceutical container distribution channels.
  • Impact of regulatory compliance on temperature controlled containers market.

Temperature Controlled Pharmaceutical Container Market Report Scope

Attribute Details
Estimated Market Size (2024) USD 4.8 billion
Projected Market Size (2034) USD 7.7 billion
Anticipated Growth Rate (2024 to 2034) 4.8%
Forecast Period 2024 to 2034
Historical Data Available for 2019 to 2023
Market Analysis USD million or billion for Value and Units for Volume
Key Regions Covered North America; Latin America; Europe; Middle East & Africa (MEA); East Asia; South Asia and Oceania
Key Countries Covered United States, Canada, Brazil, Mexico, Germany, Spain, Italy, France, United Kingdom, Russia, China, India, Australia & New Zealand, GCC Countries, and South Africa
Key Segments Covered By Product Type, By Application, By Control Type, By Content Type, and By Region
Key Companies Profiled Pelican Biothermal; Sonoco Product Company; Cryopak; Cold Chain Technologies; Envirotainer Ltd; Sofigram SA Ltd; Va Q Tec AG; Inmark Packaging; Softbox Systems; Sealed Air Corporation; Tempack; Intelsius; Saeplast Americas Inc.; Euroengel Srl; Klinge Corporation
Report Coverage Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives
Customization & Pricing Available Upon Request

Key Segments Covered by Temperature Controlled Pharmaceutical Container Industry Survey Report

By Product Type:

  • Chest Style
  • Upright Style

By Application:

  • Frozen
  • Chilled
  • Ambient

By Control Type:

  • Active
  • Passive

By Content Type:

  • Vaccines or Drugs (IV)
  • Samples (Blood, Biopsy, Etc.)
  • Reagents
  • Genetic Materials

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia and Pacific
  • Middle East and Africa (MEA)

Frequently Asked Questions

How Big is the Temperature Controlled Pharmaceutical Container Market Currently?

The market is estimated to be around USD 4.8 billion in 2024.

What is the Growth Outlook of the Temperature Controlled Pharmaceutical Container Market?

The market is set to progress at a 4.8% CAGR during the forecast period.

What is the Projected Market Value by 2034?

The market is predicted to be valued at USD 7.7 billion by 2034.

What was the Historical Size of the Market?

The market was valued at USD 3.5 billion in 2019.

Which Regional Market has the Highest Growth Potential?

India to follow 6% CAGR in sales of temperature controlled pharmaceutical containers through 2034.

Table of Content
	1. Executive Summary
	2. Market Overview
	3. Market Background
	4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
	5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Control Type
		5.1. Active
		5.2. Passive
	6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Form
		6.1. Chest Style
		6.2. Upright Style
	7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application
		7.1. Frozen
		7.2. Chilled
		7.3. Ambient
	8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Content Type
		8.1. Vaccines/Drugs (IV)
		8.2. Samples (Blood, Biopsy, Etc.)
		8.3. Reagents
		8.4. Genetic Materials
	9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
		9.1. North America
		9.2. Latin America
		9.3. Western Europe
		9.4. Eastern Europe
		9.5. South Asia and Pacific
		9.6. East Asia
		9.7. Middle East and Africa
	10. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
	11. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
	12. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
	13. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
	14. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
	15. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
	16. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
	17. Key Countries Market Analysis
	18. Market Structure Analysis
	19. Competition Analysis
		19.1. Pelican Biothermal
		19.2. Sonoco Product Company
		19.3. Cryopak
		19.4. Cold Chain Technologies
		19.5. Envirotainer Ltd
		19.6. Sofigram SA Ltd
		19.7. Inmark Packaging
		19.8. Softbox Systems
		19.9. Sealed Air Corporation
		19.10. Tempack
		19.11. Intelsius
		19.12. Saeplast Americas Inc.
	20. Assumptions & Acronyms Used
	21. Research Methodology
Recommendations

Packaging

Pharmaceutical Packaging Market

April 2024

REP-GB-6150

304 pages

Packaging

Temperature Controlled Pharmaceutical Packaging Solutions Market

February 2024

REP-GB-1446

200 pages

Packaging

Pharmaceutical Container Market

October 2023

REP-GB-9410

333 pages

Explore Packaging Insights

View Reports
Future Market Insights

Temperature Controlled Pharmaceutical Container Market

Schedule a Call